ABSTRACT
A series of 9 quinolines and 18 styrylquinolines was evaluated for the drugs'
in vitro
antileishmanial activities and cytotoxicities. The 7-aroylstyrylquinoline scaffold appeared to be the most promising one, with the most interesting compound, no. 35, exhibiting a 50% inhibitory concentration (IC
50
) of 1.2 μM and a selectivity index value of 121.5. Compound 35 was 10-fold and 8-fold more active than miltefosine and sitamaquine, the reference compounds, with selectivity indexes 607-fold and 60-fold higher, respectively.
摘要
对一系列 9 种喹啉类和 18 种苯乙烯喹啉类药物的
体外
抗利什曼病活性和细胞毒性。7-aroylstyrylquinoline 支架似乎是最有前途的支架,其中最有趣的化合物是 No.35号化合物显示出50%的抑制浓度(IC
50
)为 1.2 μM,选择性指数值为 121.5。与参考化合物米替福新和西他马喹相比,35 号化合物的活性分别提高了 10 倍和 8 倍,选择性指数分别提高了 607 倍和 60 倍。